breast cancer cell lines bt474 (ATCC)
Structured Review
Breast Cancer Cell Lines Bt474, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 4076 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bt474+cell+lines/BT-474/10__21203_slash_rs__3__rs___10431382_slash_v1-56-1-13
Average 99 stars, based on 4076 article reviews
Images
Related Articles
Next-Generation Sequencing:Article Title: Recommendations related to the analytical equivalence assessment of gene panel testing Article Snippet: .. NGS analysis of mixture cell block standard for CNV of EGFR and ERBB2 BT20 and Blocking Assay:Article Title: Recommendations related to the analytical equivalence assessment of gene panel testing Article Snippet: .. NGS analysis of mixture cell block standard for CNV of EGFR and ERBB2 BT20 and Cell Culture:Article Title: ACSS1 co-opts acetyl-CoA metabolism to drive DNA repair and undermine radiotherapy efficacy in breast cancer. Article Snippet: .. MATERIALS AND METHODS Cell culture, transfection and treatment MDA-MB-231 and Article Title: Neratinib plus dasatinib is highly synergistic in HER2-positive breast cancer in vitro and in vivo. Article Snippet: Background: HER2-targeted therapies have revolutionised the treatment of HER2-positive breast cancer.. However, de novo resistance or the emergence of acquired resistance is a persistent clinical problem.. Here we report that neratinib, an irreversible pan-HER inhibitor, in combination with the multi-kinase inhibitor dasatinib, currently used to treat certain leukemias, has strong anti-proliferative effects against models of HER2-positive breast cancer that are innately resistant to trastuzumab or have acquired resistance to neratinib. Article Title: ACSS1 co-opts acetyl-CoA metabolism to drive DNA repair and undermine radiotherapy efficacy in breast cancer Article Snippet: .. MDA-MB-231 and Article Title: Neratinib plus dasatinib is highly synergistic in HER2-positive breast cancer in vitro and in vivo Article Snippet: .. HCC1954, HCC1569, JIMT-1, SKBR3, EFM192A, and Transfection:Article Title: ACSS1 co-opts acetyl-CoA metabolism to drive DNA repair and undermine radiotherapy efficacy in breast cancer. Article Snippet: .. MATERIALS AND METHODS Cell culture, transfection and treatment MDA-MB-231 and Multiple Displacement Amplification:Article Title: ACSS1 co-opts acetyl-CoA metabolism to drive DNA repair and undermine radiotherapy efficacy in breast cancer. Article Snippet: .. MATERIALS AND METHODS Cell culture, transfection and treatment MDA-MB-231 and Article Title: ACSS1 co-opts acetyl-CoA metabolism to drive DNA repair and undermine radiotherapy efficacy in breast cancer Article Snippet: .. MDA-MB-231 and |
